CD24 and cancer: We have found that compound 1 significantly decreased the number and percentage of CD15s+ cells within three subpopulations: CD44+CD24− cancer stem cells, CD44− epithelial cells, and CD44+CD24+ cells that exhibit mesenchymal and epithelial features (Figure 3, Figure 4 and Figure 5).